Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Expert Opinion on Investigational Drugs|August 10, 2019
Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an updateEgle Ramelyte, Reinhard Dummer, Emmanuella Guenova
Expert Opinion on Drug Safety|October 15, 2016
The safety of anti PD-1 therapeutics for the treatment of melanomaEgle Ramelyte, Sabrina A Schindler, Reinhard Dummer
Expert Opinion on Pharmacotherapy|August 19, 2016
Sonidegib for the treatment of advanced basal cell carcinomaEgle Ramelyte, Valerie C Amann, Reinhard Dummer
Dermatology (Basel, Switzerland)|April 3, 2019
Radiotherapy in Periocular Cutaneous Malignancies: A Retrospective StudyDiana Lazarevic, Egle Ramelyte, Reinhard Dummer, et al.
Photodermatology, Photoimmunology & Photomedicine|February 7, 2020
Evaluation of the minimal erythema dose for UVB and UVA in context of skin phototype and nature of photodermatosisMichèle Welti, Egle Ramelyte, Reinhard Dummer, et al.
Frontiers in Oncology|August 28, 2020
Innovative Therapeutic Approaches in Primary Cutaneous B Cell LymphomaClaudia C V Lang, Egle Ramelyte, Reinhard Dummer
The Journal of Dermatology|July 18, 2025
Pruritus Is an Indicator for Quality of Life in Cutaneous T-Cell LymphomaAndrea Roggo, Yves Wüest, Reinhard Dummer, et al.
Expert Review of Clinical Pharmacology|August 1, 2019
Is single versus combination therapy problematic in the treatment of cutaneous melanoma?Regina Krattinger, Egle Ramelyte, Joëlle Dornbierer, et al.
Therapeutische Umschau. Revue Therapeutique|October 1, 2025
[Escalation and de-escalation of therapy for high-risk melanomas]Reinhard Dummer, Lara Valeska Maul, Egle Ramelyte, et al.
Pageof 6